Development of novel treatment strategy to prevent progression of arteriosclerosis in dialysis patients

Development of novel treatment strategy to prevent progression of arteriosclerosis in dialysis patients - Development of novel treatment strategy to prevent progression of arteriosclerosis in dialysis patients

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000020384

Enrollment

100

Registered

2015-12-28

Start date

2006-01-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

end stage renal disease

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: All patients of 15 years and over with end-stage renal disease on peritoneal dialysis or hemodialysis at Kansai Medical University Hirakata hospital or Kansai Medical University Takii hospital.

Exclusion criteria

Exclusion criteria: not available

Design outcomes

Primary

Measure	Time frame
Vascular physiological function tests, imaging studies, peritoneal equilibration tests, and blood and urinary tests	—

Countries

Japan

Contacts

Public ContactMitsutaka Nakahigashi

Kansai Medical University Hirakata hospital second department of internal medicine

nakahimi@tnoc.kmu.ac.jp072-804-0101

Outcome results